The GLP-1
Semaglutide · Injection
A long-acting GLP-1 receptor agonist studied for appetite suppression, blood sugar control, and clinically significant weight loss.
Starting at
$199/ month
Prefer to talk first? Talk to a licensed provider.
Why it matters
What the research shows
- Studied for ~14.9% body-weight reduction at 68 weeks (STEP-1 trial)
- Reduces fasting glucose and improves HbA1c (SUSTAIN trial program)
- Explored for cardiovascular protection (SELECT — 20% MACE reduction)
- May reduce inflammation markers (hs-CRP)
- Slows gastric emptying for sustained satiety
How it works
From consult to doorstep
01
Medical intake
A short clinical questionnaire reviewed by a licensed prescriber in your state.
02
Provider review
Your clinician confirms eligibility and tailors your starting dose.
03
Shipped to you
Compounded by a licensed pharmacy, shipped cold-chain to your door.
04
Ongoing titration
Check-ins and dose adjustments — we stay until it works.
For educational reference only — not medical advice. Loop does not diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA. Your protocol is built with a licensed Loop clinician based on your goals, history, and labs.